MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

CervoMed Inc. (CRVO)

CervoMed Inc. (CRVO)

|||

Balance Sheets Overview

Debt to Asset Ratio
11.67%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses and other curre...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
22,462,577
7,941,751
8,235,469
9,437,400
Marketable securities
2,475,595
4,982,230
12,628,970
17,856,688
Prepaid expenses and other current assets
733,718
1,695,341
1,267,005
1,685,972
Deferred offering costs
320,581
493,596
320,581
269,331
Grant receivable
0
0
426,993
1,361,387
Total current assets
25,992,471
15,112,918
22,879,018
30,610,778
Total assets
25,992,471
15,112,918
22,879,018
30,610,778
Accounts payable
687,111
2,272,497
1,454,118
1,349,219
Accrued expenses and other current liabilities
2,345,063
2,224,706
3,201,999
3,250,095
Total current liabilities
-
-
4,656,117
-
Total liabilities
3,032,174
4,497,203
4,656,117
4,599,314
Common stock, 0.001 par value 1,000,000,000 shares authorized at march 31, 2026 and december 31, 2025 9,258,719 and 9,252,719 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
13,526
9,258
9,252
9,252
Additional paid-in capital
135,180,330
116,268,674
115,905,684
115,606,949
Accumulated other comprehensive (loss) income
106
-208
5,816
5,824
Accumulated deficit
-112,233,665
-105,662,009
-97,697,851
-89,610,561
Total stockholders' equity
22,960,297
10,615,715
18,222,901
26,011,464
Total liabilities and stockholders' equity
25,992,471
15,112,918
22,879,018
30,610,778
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$22,462,577 (169.96%↑ Y/Y)Marketable securities$2,475,595 (-90.18%↓ Y/Y)Prepaid expenses andother current assets$733,718 (-62.65%↓ Y/Y)Deferred offering costs$320,581 (42.52%↑ Y/Y)Total current assets$25,992,471 (-31.74%↓ Y/Y)Total assets$25,992,471 (-31.74%↓ Y/Y)Total liabilities andstockholders' equity$25,992,471 (-31.74%↓ Y/Y)Total stockholders'equity$22,960,297 (-31.34%↓ Y/Y)Total liabilities$3,032,174 (-34.67%↓ Y/Y)Accumulated deficit-$112,233,665 (-37.06%↓ Y/Y)Additional paid-in capital$135,180,330 (17.23%↑ Y/Y)Accrued expenses andother current...$2,345,063 (-16.13%↓ Y/Y)Accounts payable$687,111 (-62.77%↓ Y/Y)Common stock, 0.001 parvalue 1,000,000,000...$13,526 (46.20%↑ Y/Y)Accumulated othercomprehensive (loss) income$106 (113.54%↑ Y/Y)